Navigation Links
Sangamo BioSciences and Collaborators Present Data Showcasing Broad Applications of ZFP Therapeutics®
Date:5/23/2011

RICHMOND, Calif., May 23, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that data from clinical, preclinical and research-stage programs focused on the development of zinc finger DNA-binding protein (ZFP) Therapeutics® were described in twenty presentations given by Sangamo scientists and collaborators at the 14th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).  The meeting was held in Seattle from May 18-21, 2011.

"Sangamo's ZFP technology is revolutionizing cell and gene therapies," stated Barrie Carter, Ph.D., a member of Sangamo's scientific advisory board and President of ASGCT for 2010-2011. "ZFP Nuclease (ZFN) technology provides an efficient and precise process for editing any DNA sequence in a cell, making development of therapeutic gene-editing applications a reality.  Sangamo has ongoing human clinical trials to evaluate ZFN-based therapeutics in HIV/AIDS and ZFP transcription factors (ZFP TFs) in neuroregeneration. As this technology functions at the DNA level, it can be applied to numerous diseases and any disease-related gene."

ASGCT meeting presentations included previously described preliminary clinical data from Sangamo's ongoing Phase 1 clinical trial in HIV/AIDS (SB-728-902) as well as data from preclinical and research-stage human therapeutic programs.  Therapeutic areas included ZFN-based approaches to infectious diseases such as HIV/AIDS and monogenic diseases such as hemophilia, ADA-SCID, retinal neurodegeneration and epidermolysis bullosa.  Positive preclinical data were also presented from studies of Sangamo's ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene in an animal model of stroke.

"These data presentations illustrate the broad range of potential applications for ZFP Therapeutics including monogenic diseases,
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sangamo BioSciences Announces Presentation at the Cowen and Company 31st Annual Health Care Conference
2. Sangamo BioSciences Announces Presentation of Positive Clinical Data From Novel ZFN Therapeutic Approach for the Treatment of HIV/AIDs at Conference for Retroviral and Opportunistic Infections
3. Sangamo BioSciences Announces Presentation at the 13th Annual BIO CEO & Investor Conference
4. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
5. Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant Human Stem Cells
7. Sangamo BioSciences Receives Michael J. Fox Foundation Funding to Develop Novel Drug for the Treatment of Parkinsons Disease
8. Sangamo BioSciences Announces First Quarter 2010 Conference Call and Webcast
9. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
10. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
11. Sangamo Announces Closing of Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
(Date:8/20/2014)... TORRANCE, Calif. , Aug. 20, 2014 /PRNewswire/ ... it will be using advanced, ventilator technology from ... way to care for patients. ... breathe more naturally, compared to conventional mechanical ventilation, ... as soon as possible. Patients on mechanical ventilation ...
(Date:8/20/2014)... , Aug. 20, 2014 The National Necrotizing Fasciitis ... Davila has been successfully treated for a life threatening ... Anibal R. Gauto , Medical Director of Inpatient Wound ... Medical Center in Rancho Mirage, California . ... by Dr. John Crew at Seton Hospital in ...
Breaking Medicine Technology:The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6
(Date:8/20/2014)... have discovered that the immune system is defective in people ... why sufferers have ongoing issues with pain. , The research ... could also help to explain why some painkillers may not ... affects up to 10% of the community. There are ... gut pain, which often has the greatest impact on sufferers, ...
(Date:8/20/2014)... Hundreds of Mirena IUD lawsuits ( http://www.themirenalawsuitcenter.com/ ... allegedly injured due to spontaneous migration of the IUD ... Superior Court, Bernstein Liebhard LLP reports. According to a ... Court has established procedures regarding the production of sales ... of the proceeding’s initial disposition pool. (In Re: Mirena ...
(Date:8/20/2014)... News) -- Loss of brain cells that act as ... have trouble falling and staying asleep, a new study ... especially severe and often results in nighttime confusion and ... data from the Rush Memory and Aging Project, which ... and are being followed until death, at which point ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... been an option, but a new study shows that only ... common reasons women didn,t undergo reconstruction was that they felt ... they were focused on their cancer treatment," said lead researcher ... Kettering Cancer Center, in New York City. Also common ...
(Date:8/20/2014)... and deadliest infectious diseases in the world, killing one ... study tuberculosis have long debated its origins. New research ... to seals and sea lions that brought the disease ... there before Europeans landed on the continent. , The ... of New World Human Tuberculosis," was published in ...
Breaking Medicine News(10 mins):Health News:Pain treatments less effective for those with irritable bowel 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4Health News:Seniors' Sleep Woes May Be Linked to Loss of Brain Cells 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3Health News:New research shows seals and sea lions likely spread tuberculosis to humans 2Health News:New research shows seals and sea lions likely spread tuberculosis to humans 3
... (UPH) in Tucson, Arizona has selected Broadlane to provide an ... Financial terms were not announced. , ... ... announced today that University Physicians Healthcare (UPH) in Tucson, Arizona ...
... MONTREAL, Sept. 11 /PRNewswire-FirstCall/ - Haemacure ... company developing,high-value human plasma-derived protein products for ... second preclinical study,conducted on the use of ... sealant Hemaseel(R)HMN, in preventing the formation of ...
... Eye Institute have opened a new office to better serve their clients. ... ... Pennsylvania is proud to announce the opening of their new office in ... and the new location is currently receiving patients for eye care and ...
... to Combat Diabetes in Local,Community, NEW YORK, Sept. ... Month and to recognize those in the,Hispanic/Latino population who ... Association is hosting Feria de Salud, Por Tu Familia ... South Bronx from 11:00,a.m. - 4:00 p.m. Actor Tony ...
... Injured, workers and passersby developed psychological, respiratory woes, latest ... -- Two to three years after the 9/11 terrorist ... elevated among people enrolled in the World Trade Center ... health department study. , Released on the eve of ...
... 10 Lincoln Park Performing Arts,Center ( http://www.lppac.org/ ... on Sept. 12-14, 2008. Leading neurologist and,mind-body researcher ... present the program at the Lincoln Park facility ... various group drumming exercises,that can benefit their health. ...
Cached Medicine News:Health News:University Physicians Healthcare (UPH) Selects Broadlane to Provide Comprehensive Supply Chain Services 2Health News:University Physicians Healthcare (UPH) Selects Broadlane to Provide Comprehensive Supply Chain Services 3Health News:University Physicians Healthcare (UPH) Selects Broadlane to Provide Comprehensive Supply Chain Services 4Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 2Health News:Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model 3Health News:Northeastern Eye Institute Opens New Office 2Health News:American Diabetes Association Kicks 0ff Hispanic Heritage Month 2Health News:9/11's Health Effects Lingered for Years 2Health News:9/11's Health Effects Lingered for Years 3Health News:Lincoln Park Performing Arts Center to Host Highly Acclaimed Music and Medicine Program 2
... BVI 6100 is a handheld, noninvasive ultrasound ... easy to operate, so any staff member ... view ultrasound images from exams and print ... and reimbursement, just log on to ScanPoint®, ...
... EXP Injectable Bulking Agent is ... suspended in a water-based carrier ... Agent is indicated for the ... stress urinary incontinence due to ...
... Wire Coil and helix provide distal ... Silver Wire Construction eliminates springback and ... is designed to provide a better ... result. ,Trimmable ends provide ...
... and 600M™ malleable penile prostheses offer easy-to-use, ... limited dexterity. These implants are always rigid, ... position them in an erect or concealed ... enough for sexual intercourse and to not ...
Medicine Products: